Discontinued — last reported Q4 '25

Financing

Sale of Subsidiary Stock

Bunge Sale of Subsidiary Stock decreased by 30.4% to $16.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 128.6%, from $7.00M to $16.00M. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalHigher is better
VolatilityVolatile
First reportedQ1 2015
Last reportedQ4 2025

How to read this metric

An increase signals a strategic divestiture or portfolio optimization, potentially providing a one-time cash infusion.

Detailed definition

Reflects the cash proceeds received from the divestiture or partial sale of equity interests in a subsidiary or business...

Peer comparison

Often appears during corporate restructuring or when a company exits a specific market or product line.

Metric ID: wmt_sale_of_subsidiary_stock

Historical Data

6 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q1 '26
Value$15.00M$16.00M$8.00M$7.00M$23.00M$16.00M
QoQ Change+6.7%-50.0%-12.5%+228.6%-30.4%
YoY Change-53.3%+43.8%+128.6%
Range$7.00M$23.00M
CAGR+5.3%
Avg YoY Growth+39.7%
Median YoY Growth+43.8%

Frequently Asked Questions

What is Bunge's sale of subsidiary stock?
Bunge (BG) reported sale of subsidiary stock of $16.00M in Q1 2026.
How has Bunge's sale of subsidiary stock changed year-over-year?
Bunge's sale of subsidiary stock increased by 128.6% year-over-year, from $7.00M to $16.00M.
What does sale of subsidiary stock mean?
Cash received from selling shares or ownership stakes in a subsidiary.